Katsuhiro Ito

23PUBLICATIONS
41CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMajor global burdens of diseaseRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Feb 17, 2026
Phenotype of circulating tumor-reactive T cells predicts immune checkpoint inhibitor response in non-small cell lung cancer.

Katsuhiro Ito, Kei Iida, Tomoko Hirano

|Jul 18, 2025
Assessing Response Durability and Survival After Second-Line Pembrolizumab in Advanced Urothelial Carcinoma: A Multicenter Validation of a Risk Model.

Samer Salah, Katsuhiro Ito, Yuki Kita

|Feb 11, 2025
Impact of lymph node dissection during surgery on the efficacy of pembrolizumab in patients with metastatic urothelial carcinoma.

Toru Kanno, Katsuhiro Ito, Yuki Kita

|Feb 04, 2025
Determinants of health-related quality of life in patients undergoing medical expulsion therapy for acute renal colic.

Katsuhiro Ito, Toshifumi Takahashi, Shigeki Koterazawa

|Feb 02, 2024
Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan.

Yuki Kita, Hikari Otsuka, Katsuhiro Ito

|Jun 06, 2023
Preoperative risk classification for intravesical recurrence after laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma in a multi-institutional cohort.

Shinya Somiya, Go Kobori, Katsuhiro Ito

Pageof 4

Frequent Collaborators

12 joint publications

Takashi Kobayashi

9 joint publications

Toru Kanno

6 joint publications

Yuki Kita

3 joint publications

Akira Yokomizo